MolecuLight Revenue and Competitors

Toronto, ON CAN

Location

#1264

Growjo Ranking

Estimated Revenue & Valuation

  • MolecuLight's estimated annual revenue is currently $7.5M per year.(i)
  • MolecuLight's estimated revenue per employee is $125,500
  • MolecuLight's total funding is $29.2M.

Employee Data

  • MolecuLight has 60 Employees.(i)
  • MolecuLight grew their employee count by 15% last year.

MolecuLight's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
CEO at MolecuLight IncReveal Email/Phone
3
VP, ReimbursementReveal Email/Phone
4
EVP Sales, AmericasReveal Email/Phone
5
ControllerReveal Email/Phone
6
Director, Regulatory Affairs, Compliance & QualityReveal Email/Phone
7
Director Advanced DevelopmentReveal Email/Phone
8
Director Product DevelopmentReveal Email/Phone
9
Chief Marketing OfficerReveal Email/Phone
10
Director Clinical Education and Distributor SupportReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.1M124-4%N/AN/A
#2
$4M16-6%N/AN/A
#3
$78.3M3129%N/AN/A
#4
$23.1M926%N/AN/A
#5
$9.3M379%N/AN/A
#6
$75.3M2403%$53.9MN/A
#7
$267.6M106613%N/AN/A
#8
$36.6M0N/A$1.3BN/A
#9
$30.9M123-20%N/AN/A
#10
$8.5M34-17%N/AN/A
Add Company

What Is MolecuLight?

ABOUT US: MolecuLight Inc. is a privately owned, Canadian medical imaging company founded by Dr. Ralph DaCosta and incorporated on June 1, 2012. The company?s first product, the MolecuLight i:X, is a first-of-its kind handheld imaging device based on Dr. DaCosta?s invention. MolecuLight is based in Toronto, Canada and has an exclusive global distributor partnership with Smith & Nephew. OUR MISSION: MolecuLight?s mission is to become the ubiquitous name in fluorescence-guided imaging technologies to improve health outcomes for patients globally through innovative products and services that optimize the delivery of health care and become standard of care in wound care and breast cancer. DISCLAIMER: The MolecuLight i:X? Imaging Device is approved by Health Canada (Medical License #95784) and has CE marking (Certificate #G1160292355002) for sale in Canada and the European Union. The MolecuLight i:X? Imaging Device has received FDA De Novo clearance. MolecuLight® and Look to Heal® are registered trademarks in Canada, the US and the EU. Follow us on Twitter and YouTube: @moleculight

keywords:N/A

$29.2M

Total Funding

60

Number of Employees

$7.5M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MolecuLight News

2022-04-06 - MolecuLight i:X® Receives Regulatory Clearance and ...

KOVE Inc. to Distribute the MolecuLight Product Suite to Large South Korean Wound Care Market. TORONTO and SEOUL, South Korea, April 6,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.6M600%N/A
#2
$6.5M609%N/A
#3
$11.3M60-6%N/A
#4
$13.1M60-17%N/A
#5
$7.6M6040%$13M